Fatty liver in adults with type 1 diabetes
Part of Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how common fatty liver disease is in people with type 1 diabetes and what might increase the risk. By joining, you could help doctors understand and better manage liver health for people with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with type 1 diabetes or LADA for at least one year.
- You do not drink more than 2 drinks (women) or 3 drinks (men) per day on a regular basis.
- You do not have any other chronic liver disease (like hepatitis or cirrhosis).
- You are not currently taking certain medications that can cause fat buildup in the liver (like corticosteroids, tamoxifen, or methotrexate).
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common a certain type of fatty liver disease (called MASLD) is in adults with Type 1 diabetes. The goal is to learn more about liver health in people with Type 1 diabetes to help improve care.
This trial looks at how common fatty liver disease is in people with type 1 diabetes. Doctors will check your liver with tests to learn more and find out if you might be at risk.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
This study tests whether a supplement called butyrate or an intensive lifestyle program can help reduce fat in the liver for people with type 1 diabetes. It aims to improve liver health and possibly make blood sugar management easier.
This study looks at how fat tissue works differently in people with type 1 diabetes who have extra belly fat, and how that may lead to fat building up in the liver. It compares them to people without diabetes to better understand the link.
This study looks at how early biological aging might increase the chance of developing type 2 diabetes in people with a fatty liver (a condition called MASLD). It uses routine health check-up data to understand the link.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.